JB

John Bondo Hansen

Director Director DIN 02045276
DIN 02045276 First appointment Jul 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2008
Shareholding value Locked Premium profile

About John Bondo Hansen

Data last updated:

John Bondo Hansen has 18 years in corporate governance. Formerly with 1 company, such as Aurigene Oncology Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02045276
Primary Designation Director
First Appointment 10 Jul 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Aurigene Oncology Limited U24239KA2001PLC029391
Director10 Jul 20082001Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aurigene Oncology Limited
Premium access

Shareholding and investment profile for John Bondo Hansen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Bondo Hansen

John Bondo Hansen has 18 years in corporate governance. Formerly with 1 company, such as Aurigene Oncology Limited. Engaged in General Business. Contributes to corporate operations.

John Bondo Hansen is associated with 0 companies as a director.

John Bondo Hansen has expertise in General Business.

John Bondo Hansen has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available